Health
AbbVie Highlights Innovative Research From Its Rheumatology Portfolio at ACR Convergence 2021 – StreetInsider.com
NORTH CHICAGO, Ill., Nov. 1, 2021 /PRNewswire/ –Â AbbVie (NYSE: ABBV) today announced the presentation of new data on…
NORTH CHICAGO, Ill., Nov. 1, 2021 /PRNewswire/ – AbbVie (NYSE: ABBV) today announced the presentation of new data on RINVOQ® (upadacitinib), SKYRIZI® (risankizumab) and HUMIRA® (adalimumab) across multiple rheumatic diseases at the American College…
Continue Reading
-
Noosa News18 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business22 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General23 hours agoRush to buy homes before rate cuts send prices soaring
-
Business20 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025